A Fixed-Duration Immunochemotherapy Approach in CLL: 5.5-Year Results from the Phase 2 ICLL-07 FILO Trial.
Anne-Sophie Michallet,Remi Letestu,Magali Le Garff-Tavernier,Lydia Campos,Michel Ticchioni,Marie-Sarah Dilhuydy,Stephane Morisset,Valerie Rouille,Beatrice Mahe,Kamel Laribi,Bruno Villemagne,Emmanuelle Ferrant,Olivier Tournilhac,Alain Delmer,Lysiane Molina,Veronique Leblond,Cecile Tomowiak,Sophie de Guibert,Frederique Orsini-Piocelle,Anne Banos,Philippe Carassou,Guillaume Cartron,Luc Mathieu Fornecker,Loic Ysebaert,Caroline Dartigeas, Margot Truchan-Graczyk,Jean-Pierre Vilque,Therese Aurran Schleinitz,Florence Cymbalista,Stephane Lepretre,Vincent Levy,Florence Nguyen-Khac BLOOD ADVANCES（2023）
关键词
Immunoglobulin Replacement Therapy,Ibrutinib
AI 理解论文
溯源树
样例
